Does Kv3 channel modulation reduce dopamine synthesis capacity and reduce abnormal neural responses in schizophrenia?

Project: Research

Project Details

StatusFinished
Effective start/end date1/07/201530/06/2018

Collaborative partners

  • King's College London (lead)
  • Autifony Therapeutics Ltd
  • University of Manchester
  • Newcastle University
  • Hammersmith Hospital
  • SLaM South London and Maudsley NHS Foundation Trust

Funding

  • Innovate UK: £364,577.00